The Evolving Field of Treatment ModalitiesVideo Categories: 2018 AONN Midyear, Immunotherapy, and Video Library
Dr Morganna Freeman considers the future application of treatment modalities and how they might be combined for optimal results.
As we learn more about a person’s genetic makeup, the more we are able to target medicines to his/her needs and benefit. With continued research, Dr. Stainthorpe explains, we will be able to identify markers that allow us to target medicines more precisely to get better performance and reduce waste.
Dr. Sanjiv Agarwala brings up the potential issue of toxicity that may arise in combining immunotherapies and argues that the benefits outweigh the risks.